Breaking News
Sort by:
Top Post
INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect […]
Degron Therapeutics Co-Founder Provides New Strategy for Molecular Glue in Tumor Immunotherapy
Degron Therapeutics (“Degron”), a biotechnology company developing a new class of small-molecule medicines that target […]
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolerability, and […]
GSK Presents Promising New Data for Bepirovirsen, an Investigational Treatment for Chronic Hepatitis B
GSK plc today announced promising interim results from the B-Clear phase IIb trial showing that […]
Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH
Echosens, a high-technology company offering liver diagnostic solutions, and Novo Nordisk A/S, a leading global […]
Targovax Announces That the FDA Has Granted Authorization to Initiate Clinical Trials With the Enhanced TG01 RAS Vaccine in the USA
Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid […]
Onward Therapeutics Made a Second Strategic Equity Investment in Emercell for Their NK Cell Technology in Cancer Immunotherapy
Onward Therapeutics SA (Onward Therapeutics) and Emercell SAS (Emercell) announced today the recent exercise of […]
Sanofi-GSK Next-generation COVID-19 Booster Delivers Strong Immune Response Against Variants of Concern, Including Omicron
Sanofi today reports data from two trials, VAT02 Cohort 2 and COVIBOOST VAT013, conducted with […]
Endo Tools Therapeutics Receives Positive Opinion From French High Authority for Health on Forfait Innovation Scheme to Treat Patients With Diabetes
Endo Tools Therapeutics (ETT), a company developing advanced endoscopic medical devices, today announces that HAS, […]
Cancer Vaccine Biotech CimCure Raises € 5 Million in Seed Round Investment Led by Positron Ventures
CimCure, a biotech spin-off of Amsterdam UMC, focusing on the development of a novel vaccine-based […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more